LGND - Ligand Pharmaceuticals Incorporated

Name: Ligand Pharmaceuticals Incorporated Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Classified under Biotechnology (Health Care sector), LGND's insider flows are most useful compared with peers in the same group.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Davis Todd C	188.9K	$34.72M	-
Dir	Aryeh Jason	102.6K	$25.64M	-
Dir	Kozarich John W	41.8K	$2.90M	-
Other	Reardon Andrew	41.4K	$2.16M	-
Dir	Lamattina John L	27.0K	$6.67M	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 12, 2026	Haas Jason	Director	Sale+OE	6,461	$255.58	$1,651,320.20	-56.5%	+13.2%	-
Jun 11, 2026	Aryeh Jason	Director	Sell	5,000	$250.00	$1,250,000.00	-4.6%	+13.2%	-
Jun 10, 2026	Lamattina John L	Director	Sell	4,591	$250.88	$1,151,774.29	-14.5%	+16.4%	-
May 13, 2026	Kozarich John W55	Director	Sale+OE10b5-1	2,501	$225.14	$563,079.63	-5.6%	+30.5%	-
May 1, 2026	Reardon Andrew	CLO &Secretary	Sale+OE10b5-1	5,000	$231.31	$1,156,555.60	-10.8%	+30.3%	-
Apr 1, 2026	Kozarich John W55	Director	Sell10b5-1	467	$202.23	$94,440.09	-1.1%	+58.3%	-
Apr 1, 2026	Reardon Andrew	CLO &Secretary	Sale+OE10b5-1	5,000	$201.24	$1,006,224.10	-10.8%	+58.3%	-
Mar 6, 2026	Lamattina John L	Director	Sale+OE	2,161	$200.76	$433,842.36	-6.6%	+16.8%	-
Mar 4, 2026	Reardon Andrew	CLO &Secretary	Sale+OE10b5-1	5,000	$206.35	$1,031,770.27	-11.9%	+11.4%	-
Mar 4, 2026	Espinoza Octavio48	Chief Financial Officer	Sale+OE10b5-1	13,423	$205.83	$2,762,822.25	-38.3%	+11.4%	-

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC